Gut region-specific accumulation of reactive oxygen species leads to regionally distinct activation of antioxidant and apoptotic marker molecules in rats with STZ-induced diabetes

The International Journal of Biochemistry & Cell Biology
Zsanett JancsóEdit Hermesz

Abstract

The aim of this study was to seek possible links between the regionality along the digestive tract and the accumulation of reactive oxygen species, the effectiveness of the antioxidant defense system and the sensitivity to the types of demise in different gut regions of rats with streptozotocin-induced diabetes. Significant changes were observed in the oxidative status and in the activity of the antioxidant defense system in the diabetic colon; the peroxynitrite production was doubled, the level of hemoxygenase-2 protein was increased 11-fold and the expression of anti-apoptotic bcl-2 was also increased. The segment-specific vulnerability of the gastrointestinal tract induced by hyperglycemia was also confirmed by electron microscopy, demonstrating the presence of severe necrosis in the colon of the diabetic rats. No remarkable histopathological alterations were seen in the duodenum of the diabetic animals and there were likewise no significant changes in the production of peroxynitrite in their duodenum, whereas the level of the free radical scavenger metallothionein-2 was increased ∼300-fold. The spatially restricted vulnerability observed along the digestive tract could originate from a high level of oxidative stress via per...Continue Reading

References

Nov 1, 1995·American Journal of Respiratory Cell and Molecular Biology·L OtterbeinA M Choi
Mar 29, 1994·Proceedings of the National Academy of Sciences of the United States of America·G F VileR M Tyrrell
Jan 1, 1993·Free Radical Research Communications·R E Huie, S Padmaja
Aug 28, 1998·Science·A Ashkenazi, V M Dixit
Aug 28, 1998·Science·N A Thornberry, Y Lazebnik
Feb 16, 2002·Methods : a Companion to Methods in Enzymology·K J Livak, T D Schmittgen
Jun 14, 2002·International Journal of Oncology·Darja KanducEmanuel Farber
Dec 10, 2002·Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·J ZhaoH Gregersen
Feb 5, 2003·Experimental Cell Research·Sergey Ya ProskuryakovVladimir L Gabai
Sep 2, 2003·The Journal of Pathology·Laurens KruidenierHein W Verspaget
Jun 26, 1953·Science·R F BEERS, I W SIZER
Feb 10, 2004·The Journal of Physiology·Simon J Gibbons, Gianrico Farrugia
May 12, 2004·Current Pharmaceutical Design·Carlo M BergaminiCarlo Cervellati
Dec 17, 2005·Antioxidants & Redox Signaling·Mahin D Maines
Jan 24, 2007·Physiological Reviews·Pál PacherLucas Liaudet
Dec 7, 2007·BioFactors·Md Shahidul Islam, Du Toit Loots
Jul 3, 2009·American Journal of Physiology. Renal Physiology·Nader G AbrahamGeorge Drummond
Nov 11, 2009·Science·Tracey A Rouault
Sep 4, 2010·Antioxidants & Redox Signaling·Stephen W Ragsdale, Li Yi
May 24, 2011·World Journal of Surgical Oncology·N ThirumoorthyMalay Chatterjee
Feb 3, 2012·Microcirculation : the Official Journal of the Microcirculatory Society, Inc·Nikolett BódiMária Bagyánszki

❮ Previous
Next ❯

Related Concepts

Related Feeds

Biomarkers for Diabetes

This feed focuses on the latest research on biomarkers used for monitoring disease progression in diabetes.

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis